Coptis Japonica</Emphasis>

Total Page:16

File Type:pdf, Size:1020Kb

Coptis Japonica</Emphasis> Plant Cell Reports (1988) 7:1-4 Plant Cell Reports © Springer-Verlag 1988 Alternative final steps in berberine biosynthesis in Coptisjaponica cell cultures E. Galneder 1 M. Rueffer 1, G. Wanner 1, 2, M. Tabata 1, 3, and M. H. Zenk 1 1 Lehrstuhl tar Pharmazeutische Biologie der Universitfit Mfinchen, Karlstrasse 29, D-8000 Mt~nchen 2, Federal Republic of Germany 2 Botanisches Institut der Universitfit Miinchen, Menzinger Strasse 67, D-8000 Manchen 19, Federal Republic of Germany 3 Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto 606, Japan Received October 30, 1987 - Communicated by K. Hahlbrock ABSTRACT oxidase (STOX) reported from our laboratory (Amann et al., 1984) in that the Coptis enzyme dehydrogenated In Coptis japonica cell cultures an alternative path- only (S)-canadine while other tetrahydroprotober- way has been discovered which leads from (S)-tetra- berines were reported to be inactive. In further hydrocolumbamine via (S)-canadine to berberine. The contrast to the STOX enzyme, their enzyme did not two enzymes involved have been partially purified. produce hydrogen peroxide but rather H20 as one of (S)-Tetrahydrocolumbamine is stereospecifically the reaction products. Our analysis of the Coptis transformed into (S)-canadine under formation of the system reported here led to the surprising result methylenedioxy bridge in ring A. This new enzyme was that the terminal two steps in the biosynthesis of named (S)-canad/ne synthase. (S)-Canadine in turn is berberine in 8erberis and Coptis are biochemically stereospecifically dehydrogenated to berberine by an completely different while similar at the cytological oxidase, (S)-canadine oxidase (COX), which was level. partially purified (25-fold). This enzyme has many physical properties in common with the already known MATERIAL and METHODS (S)-tetrahydroprotoberberine oxidase from Berberis but grossly differs from the latter enzyme in its co- CELL CULTURES - B. stolonifera was cultivated in factor requirement (Fe) and /ts substrate specif- Linsmaier and Skoog (1965) medium as previously icity. Neither (S)-norreticuline nor (S)-scoulerine described (Amann et al., 1986), and C. japonica under serves as substrate for the Coptis enzyme, while both conditions as given by Fukui et al. (1982). substrates are readily oxidized by the Berberis enzyme. The four terminal enzymes catalyz/ng the ENZYME PREPARATION - Cells of C. japonica were pathway from (S)-reticuline to berberine are housed harvested after 10 days of cultivation and frozen in in Berberis as well as in Coptis in smooth vesicles liquid nitrogen. Typically 100 g fresh weight were with a density of p = 1.14 g/ml. These vesicles have thawed while stirring in 200 ml 10 mM phosphate been enriched and characterized by electron micro- buffer (pH 7.5, 5 mM B-mercaptoethanol). After 30 min scopy. the mass was pressed through cheese-cloth and centrifuged for 10 min at 13 500 x g. The clear INTRODUCTION supernatant was applied to an XAD-2 column (XAD-2, 0.31 - I mm, Serva Heidelberg, column: 2.5 x 15 cm, Berberine is the first plant alkaloid whose bio- flow rate: 100 ml/h), equilibrated with 10 mM phos- synthesis is completely known at the enzyme level phate buffer (pH 7.5, 5 mM 3-mercapotethanol). The (Zenk et al., 1985). Recently the early steps in the eluate of the column (230 ml) was applied to a DEAE- pathway leading from tyrosine to reticuline, the Sephacel column (Pharmacia, 2.5 x 18 cm, flow rate universal precursor for isoquinoline alkaloids, had 35 ml/h) equilibrated with the buffer described to be revised (Stadler et al., 1987) in that norcoc- above. The protein was eluted with a linear gradient laurine was recognized as the first alkaloid inter- of KCI (0 - I M KCI, 8 h) in fractions of 5 ml. The mediate in reticuline biosynthesis (Loeffler et al., oxidase was detected in fractions 125 - 142 (92 ml) 1987). The berberine pathway has been worked out which were pooled and dialyzed against 10 mM phos- mainly using cell cultures of different Berberis phate buffer (pH 7.5, 5 mM 3-mercaptoethanol). The species as the experimental material. Cell suspension dialyzed enzyme solution was applied to a QAE-coiumn cultures of Coptis japonica, on the other hand, have (QAE fast flow, FPLC-system Pharmacia, 1.0 x 10 cm) been optimized to such a degree that the commercial at a flow rate of I ml/min equilibrated with the production of berberine seems now feasable (see standard phosphate buffer. The enzyme was eluted with Fujita and Tabata, 1987). In order to understand the a linear gradient from 0 - 0.3 M KOI (70 min, flow alkaloid biosynthesis at the biochemical and cyto- rate: I ml/min) in I ml fractions. The enzyme was logical level in this tissue we set out to compare detected in fractions 44 - 64 (20 ml), pooled and the pathway for berberine formation in Coptis with dialyzed again against the standard buffer. The the established pathway in our Berberis system. This resulting protein solution was bound to a red A- study was justified due to the report of Yamada and column (Procion red (Ciba-Geigy) bound to TSK-gel Okada (1985) on a crude enzyme from Coptis which (Merck)) at a flow rate of 15 ml/h (column: 1.5 x 30 converted (S)-tetrahydroberberine (= (S)-canadine) to cm, equilibrated with standard buffer). The protein berberine. This unpurified enzyme was strikingly was incubated on the column for 2 h and afterwards different from the (S)-tetrahydroprotoberberine the enzyme could be eluted with the equilibration Offprint requests to: M. H. Zenk buffer (36 ml), about a 25-fold purification resulted were dehydrogenated as we11, while scoulerine and with a specific activity of 6.5 pkat/mg. The mole- norreticuline were not. The 58 kD enzyme which was cular weights of the enzymes were determined.by gel present in the ceils predominantly (ca. 60%) was filtration HPLC (G-3000 SW, LKB, 21.5 x 600 mm). The further characterized and compared to the enzyme from isoelectric point was determined by preparative iso- Berberis wilsoniae. electric focusing in a granulated flat agarose gel from pH 4.5 - 6.0 (LKB).Protein determinations were performed according to Bradford (1976). Enzyme activity in % Substrate 155 kD 58 kD ENZYME ASSAYS - The reaction mixture (250 ~i) included 25 ~moles borate buffer (pH 8.9), I nmole (s)-Canadine 100 100 (R,S)-[8,14-tritium]-canadine (20 000 cpm) and enzyme (up to 300 ~g protein). The assay mixture was (R)-Canadine 0 0 incubated for 20 min at 30°C and the reaction termin- (R,S)-Stylopine 11 26 ated by addition of 300 ~i dextran coated charcoal (I g/10 ml). The suspension was centrifuged for 5 min (R,S)-Tetrahydrocolumbamine 5 5 in an Eppendorf centrifuge and an aliquot of 250 ~I (R,S)-Scoulerine 0 0 removed for scintillation counting (Rotiszint 22, Roth). The optical assay was performed using the (R,S)-Norreticuline 0 0 stereochemically pure isoquinoline alkaloids accord- ing to Amann et al. (1986). (S)-Canadine synthase was assayed as stated previously (Rueffer and Zenk, Table 1 Substrate specificity of the high and low mole- 1985), however, using (R,S)-[3-methoxy-tritium]- cular weight forms of Coptis (S)-canadine oxidase. The tetrahydrocolumbamine. assay conditions were given in material and methods. VESICLE ISOLATION AND ELECTRON MICROSCOPY - The vesicles were isolated by isopycnic sucrose density Both enzymes are very similar~ in their physical gradient centrifugation and characterized by electron properties they show the same pH (Berberis: pH 8.9, microscopy according to Amann et aI. (1986). Atomic Coptis: pH 8.7) and temperature optimum (40°C), they absorption spectroscopy (graphite column mode) was both occur in a higher and lower M~ form, they have performed on a Perkin Elmer 1100B instrument. similar isoelectric points (pH 5.7/pH 5.3), they catalyze the dehydrogenation of only the (S)-forms of RESULTS their substrates, they both exist in specific vesic- les (see below), and the products of the reaction are ENZYMOLOGY OF BERBERINE FORMATION - C. japonica cells the quaternary protoberberine and hydrogen peroxide. grown under conditions of high berberine production One difference is, however, while the oxidase from were used as an enzyme source. Crude protein extracts Berberis is a flavin enzyme (Amann et al., 1984), the were analyzed for their ability to oxidize a variety Coptis enzyme clearly contains iron as shown by of tetrahydroprotoberberines. Using the very sens- atomic absorption spectroscopy of the electrophoret- itive tritium removal assay as well as the optical icalIy pure enzyme and by its inhibition by ortho- assay it could be shown that (S)-canadine was by far phenanthroline (50% inhibition at 0.05 mM), a behav- the best substrate (100%) followed by (S)-scoulerine iour which is not shown by the Berberis enzyme. The (16%), (R,S)-tetrahydrojatrorrhizine (15%), (R,S)- major difference, however, is seen in the substrate coreximine (7%), (R,S)-stylopine and (R,S)-tetra- specificity of both enzymes. While the Berberis hydrocolumbamine (each 6%), and by (R,S)-tetrahydro- enzyme is fully active towards (S)-scoulerine, (S)- palmatine (5%). Tetrahydroprotoberberines with (R)- canadine and (S)-norreticuline, the Coptis enzyme configuration were not utilized as substrates. The catalyzes only the oxidation of (S)-canadine. We presence of various protoberberines in this crude and therefore propose to call this enzyme (S)-canadine colored protein extract may have influenced the oxidase (COX) or (S)-tetrahydroberberine oxidase oxidase activity in a negative way and the results (Yamada and Okada, 1985), in contrast to the Berberis have to be interpreted more in a qualitative manner. enzyme which we have termed (S)-tetrahydroprotober- Regardless of this potential interference, the berine oxidase (STOX) because of its much wider experiment demonstrates the presence of oxidase substrate range.
Recommended publications
  • Pharmacokinetic Interactions Between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
    life Review Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance Laura Rombolà 1 , Damiana Scuteri 1,2 , Straface Marilisa 1, Chizuko Watanabe 3, Luigi Antonio Morrone 1, Giacinto Bagetta 1,2,* and Maria Tiziana Corasaniti 4 1 Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, 87036 Rende, Italy; [email protected] (L.R.); [email protected] (D.S.); [email protected] (S.M.); [email protected] (L.A.M.) 2 Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy 3 Department of Physiology and Anatomy, Tohoku Pharmaceutical University, 981-8558 Sendai, Japan; [email protected] 4 School of Hospital Pharmacy, University “Magna Graecia” of Catanzaro and Department of Health Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0984-493462 Received: 28 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The therapeutic efficacy of a drug or its unexpected unwanted side effects may depend on the concurrent use of a medicinal plant. In particular, constituents in the medicinal plant extracts may influence drug bioavailability, metabolism and half-life, leading to drug toxicity or failure to obtain a therapeutic response. This narrative review focuses on clinical studies improving knowledge on the ability of selected herbal medicines to influence the pharmacokinetics of co-administered drugs. Moreover, in vitro studies are useful to anticipate potential herbal medicine-drug interactions.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • Appendix Human and Rat Liver Cytochromes P450: Functional
    Appendix Human and Rat Liver Cytochromes P450: Functional Markers, Diagnostic Inhibitor Probes, and Parameters Frequently Used in P450 Studies Maria Almira Correia The tables in this appendix summarize the rel­ different P450 isoforms included in its evaluation ative functional selectivities of substrates and as well as the range of substrate/inhibitor concen­ inhibitors for the major human and rat liver trations tested. Second, substrates and inhibitors C3^ochrome P450 isoforms (P450s). These hepatic determined to be "relatively selective" for a human isoforms are well recognized to catalytically par­ liver isoform, may not necessarily be so for its rat ticipate in the metabolism of chemically diverse liver ortholog, and vice versa. Third, the relative endo- and xenobiotics including drugs, and in the metabolic contribution of a P450 isoform to the case of human liver P450s to thus contribute to in vivo hepatic metabolism of a given drug is directly clinically adverse drug-drug interactions. Conse­ proportional to the relative hepatic microsomal quently, these P450s are the targets of intense abundance of that isoform and its affinity for that scrutiny in the pharmaceutical screening of exist­ compound, irrespective of its in vitro high meta­ ing or novel chemical agents of potential clinical bolic profile assessed under "optimized" condi­ relevance for drug development. At a more basic tions. This issue arises because recent advances in level, these tables provide information on estab­ recombinant P450 technology have made unprece­ lished and/or potential diagnostic tools for the dented amounts of purified human liver enzymes identification and/or characterization of the meta­ readily available for comparative in vitro charac­ bolic role of each individual P450 in the disposition terization of drug metabolism, at relative P450 of an as yet uncharacterized xeno- or endobiotic.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Chronic Venous Insufficiency/CVI
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Chronic Venous Insufficiency/CVI Chemical Activity Count (+)-AROMOLINE 1 (+)-CATECHIN 5 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-PRAERUPTORUM-A 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-ACETOXYCOLLININ 1 (-)-APOGLAZIOVINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-EPICATECHIN 4 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 2 (-)-EPIGALLOCATECHIN-GALLATE 3 (-)-HYDROXYJASMONIC-ACID 1 (-)-N-(1'-DEOXY-1'-D-FRUCTOPYRANOSYL)-S-ALLYL-L-CYSTEINE-SULFOXIDE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 Chemical Activity Count 1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)-1,6-HEPTADIEN-3,5-DIONE 1 1,8-CINEOLE 1 1-(METHYLSULFINYL)-PROPYL-METHYL-DISULFIDE 1 1-ETHYL-BETA-CARBOLINE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-GINGEROL 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 14-ACETOXYCEDROL 1 14-O-ACETYL-ACOVENIDOSE-C 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 2,3,7-TRIHYDROXY-5-(3,4-DIHYDROXY-E-STYRYL)-6,7,8,9-TETRAHYDRO-5H-
    [Show full text]
  • Pseudoxandra Sclerocarpa Maas, Colombian Medicinal Plant: a Review [Pseudoxandra Sclerocarpa Maas, Planta Medicinal Colombiana: Una Revisión]
    Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas ISSN: 0717-7917 [email protected] Universidad de Santiago de Chile Chile Salazar, J. Rodrigo; Torres, Patrício; Serrato, Blanca; Dominguez, Mariana; Alarcón, Julio; Céspedes, Carlos L. Insect Growth Regulator (IGR) effects of Eucalyptus citriodora Hook (Myrtaceae) Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, vol. 14, núm. 5, 2015, pp. 403-422 Universidad de Santiago de Chile Santiago, Chile Available in: http://www.redalyc.org/articulo.oa?id=85641105006 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative © 2015 Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 14 (4): 308 – 316 ISSN 0717 7917 www.blacpma.usach.cl Revisión | Review Pseudoxandra sclerocarpa Maas, Colombian medicinal plant: a review [Pseudoxandra sclerocarpa Maas, planta medicinal colombiana: una revisión] Jazmin Prieto1, Diego Cortes2, Luisauris Jaimes3, Claudio Laurido4, Raul Vinet5 & José L. Martínez6 1Universidad Nacional de Colombia, sede Palmira 2Facultad de Farmacia, Universidad de Valencia, España 3Facultad de Ciencias de la Educación, Universidad de Carabobo, Valencia, Venezuela 4Facultad de Química y Biología, Universidad de Santiago de Chile 5Facultad de Farmacia, Universidad de Valparaíso, and Centro Regional de Estudios en Alimentos Saludables, Valparaíso, Chile 6Vicerrectoría de Investigación, Desarrollo e Innovación, Universidad de Santiago de Chile Contactos | Contacts: José L. MARTÍNEZ - E-mail address: [email protected] Abstract: The Annonaceae family is one of the largest, with 130 genre and 2500 species, consisting of trees, shrubs and a few vines.
    [Show full text]
  • Proquest Dissertations
    u Ottawa l.'Univcrsilc cnnndicnnc C.'inadn's linivcrsily FACULTE DES ETUDES SUPERIEURES l==l FACULTY OF GRADUATE AND ET POSTOCTORALES U Ottawa POSDOCTORAL STUDIES L'UniversitG canadienne Canada's university Renee Leduc TOTEURWEniS'SErAUTHOROrfHESiS" M.Sc. (Biology) GRADE/DEGREE Department of Biology "F7CUITOC6LTD!PARTE¥OT^^ Phytochemical Variation in Canadian Hydrastis canadensis L. (Goldenseal) and the In vitro Inhibition of Human Cytochrome P450-mediated Drug Metabolism by H. canadensis and Other Botanicals TITRE DE LA THESE / TITLE OF THESIS Dr. John T. Amason TJiRECTEURpRiC^ Dr. Robin J. Maries CO-DIRECTEUR"(CO-DIRECfRICE) DE LATHISE / THl¥s"CO^"UPERVlSOR EXAMINATEURS (EXAMINATRICES) DE LA THESE / THESIS EXAMINERS Dr. Jeremy Kerr Dr. Paul Caitling Dr. Naomi Cappuccino Gary W. Slater Le Doyen de la Faculte des etudes superieures et postdoctorales / Dean of the Faculty of Graduate and Postdoctoral Studies PHYTOCHEMICAL VARIATION IN CANADIAN HYDRASTIS CANADENSIS L. (GOLDENSEAL) AND THE IN VITRO INHIBITION OF HUMAN CYTOCHROME P450-MEDIATED DRUG METABOLISM BY H. CANADENSIS AND OTHER BOTANICALS RENEEIRENE LEDUC Thesis submitted to the Faculty of Graduate and Postdoctoral Studies University of Ottawa in partial fulfillment of the requirements for the M.Sc. degree in the Ottawa-Carleton Institute of Biology These soumise a Faculte des etudes superieures et postdoctorales Universite d'Ottawa en vue de I'obtention de la maitrise es sciences L'lnstitut de biologie d'Ottawa-Carleton © Renee I. Leduc, Ottawa, Canada, 2007 Library and Bibliotheque
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 2 (+)-ISOLARICIRESINOL 1 (+)-NORTRACHELOGENIN 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-DICENTRINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 Chemical Activity Count 1-ETHYL-BETA-CARBOLINE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 1 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID
    [Show full text]
  • A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information
    gene2drug: a Computational Tool for Pathway-based Rational Drug Repositioning Supplementary Information Francesco Napolitano1, Diego Carrella1, Barbara Mandriani1, Sandra Pisonero1, Diego Medina1, Nicola Brunetti-Pierri1,2, and Diego di Bernardo1,3 1Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (NA), 80078, Italy. 2Department of Translational Medicine, Federico II University, 80131 Naples, Italy 3Department of Chemical, Materials and Industrial Production Engineering, University of Naples Federico II, 80125 Naples, Italy. List of Figures S1 Relation between PPI network-based and pathway based approaches. Given a therapeutic gene and the set of pathways it is annotated to according to the different databases, the other genes in the same pathways are topologically closer to it in the PPI network as compared to randomly chosen genes. The average shortest path from the selected gene to other pathway members is reported on the y axis for each database. 3 S2 Size of intersection between existent evidence scores in the STITCH database (subset matched against the Cmap database) as a percentage of the total number of evidences. Numbers on the diagonal represent how many times a drug-target evidence exists divided by the total number of reported pairs. A \combined score" always exist if one of the other evidences exist, thus \combined score" covers 100% of the pairs. Conversely, an \experimental" score is only present for 14% of the pairs. The \Text mining" evidence strongly drives the \combined score" covering 61% of all the known protein-target interactions in STITCH. 4 S3 Relative luminescence units (RLU) in Hepa1-6 cells transfected with a plasmid ex- pressing the luciferase gene under the control of the GPT promoter and incubated with various concentrations of fulvestrant.
    [Show full text]
  • S41438-020-00450-6.Pdf
    Xu et al. Horticulture Research (2021) 8:16 Horticulture Research https://doi.org/10.1038/s41438-020-00450-6 www.nature.com/hortres ARTICLE Open Access Integration of full-length transcriptomics and targeted metabolomics to identify benzylisoquinoline alkaloid biosynthetic genes in Corydalis yanhusuo Dingqiao Xu1,HanfengLin 2,YupingTang1,LuHuang1,JianXu2,SihuiNian3 and Yucheng Zhao 2 Abstract Corydalis yanhusuo W.T. Wang is a classic herb that is frequently used in traditional Chinese medicine and is efficacious in promoting blood circulation, enhancing energy, and relieving pain. Benzylisoquinoline alkaloids (BIAs) are the main bioactive ingredients in Corydalis yanhusuo. However, few studies have investigated the BIA biosynthetic pathway in C. yanhusuo, and the biosynthetic pathway of species-specific chemicals such as tetrahydropalmatine remains unclear. We performed full-length transcriptomic and metabolomic analyses to identify candidate genes that might be involved in BIA biosynthesis and identified a total of 101 full-length transcripts and 19 metabolites involved in the BIA biosynthetic pathway. Moreover, the contents of 19 representative BIAs in C. yanhusuo were quantified by classical targeted metabolomic approaches. Their accumulation in the tuber was consistent with the expression patterns of identified BIA biosynthetic genes in tubers and leaves, which reinforces the validity and reliability of the analyses. Full- length genes with similar expression or enrichment patterns were identified, and a complete BIA biosynthesis pathway fi 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; in C. yanhusuo was constructed according to these ndings. Phylogenetic analysis revealed a total of ten enzymes that may possess columbamine-O-methyltransferase activity, which is the final step for tetrahydropalmatine synthesis. Our results span the whole BIA biosynthetic pathway in C.
    [Show full text]
  • In Silico Transcriptomic Analysis of Canadine Accumulation in Papaver Somniferum Cultivar
    J Biotechnol Biomed 2020; 3 (1): 024-028 DOI: 10.26502/jbb.2642-91280024 Research Article In Silico Transcriptomic Analysis of Canadine Accumulation in Papaver Somniferum Cultivar Sai Batchu* Department of Biology, The College of New Jersey, 2000 Pennington Rd. Pennington, NJ, USA *Corresponding Author: Sai Batchu, Department of Biology, The College of New Jersey, 2000 Pennington Rd. Pennington, NJ, USA, E-mail: [email protected] Received: 20 February 2020; Accepted: 13 March 2020; Published: 20 March 2020 Citation: Sai Batchu. In Silico Transcriptomic Analysis of Canadine Accumulation in Papaver Somniferum Cultivar. Journal of Biotechnology and Biomedicine 3 (2020): 024-028. Abstract Papaver somniferum, colloquially known as opium high canadine cultivar compared to the normal cultivar. poppy, currently remains as the only commercial source These findings provide basis for further elucidating the of pharmaceutically important benzylisoquinoline coordinated transcriptional processes underlying alkaloids, of which include canadine. Canadine is an canadine accumulation in P. somniferum cultivars. important naturally occurring alkaloid in current demand for pharmaceutical studies. Understanding the Keywords: Canadine; Papaver somniferum; biosynthesis in plantae will help in increasing Transcriptomic; In silico production of this alkaloid. In the present study, a comparative transcriptomic analysis was performed 1. Introduction between gene expression data procured from the normal Opium poppy (Papaver somniferum) is an important cultivar and a high canadine cultivar. Results indicated source of benzylisoquinoline alkaloids, a group of plant differential expression of key enzymes in the secondary metabolites that exhibits a multitude of phthalideisoquinoline pathway leading to canadine pharmacological activities including antimalarial [1], biosynthesis. Specifically, it was found that antispasmodic [2], analgesic [3], and antitussive [4].
    [Show full text]
  • The Medicinal Plant Goldenseal Is a Natural LDL-Lowering Agent with Multiple Bioactive Components and New Action Mechanisms
    The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms Parveen Abidi,1 Wei Chen,1 Fredric B. Kraemer, Hai Li, and Jingwen Liu2 Department of Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304 Abstract Our previous studies have identified berberine In humans, .70% of LDL-c is removed from plasma by low (BBR), an alkaloid isolated from the Chinese herb huang- density lipoprotein receptor (LDLR)-mediated uptake in lian, as a unique cholesterol-lowering drug that upregulates the liver (4). Hence, the expression level of hepatic LDLR hepatic low density lipoprotein receptor (LDLR) expression directly influences plasma cholesterol levels; therefore, through a mechanism of mRNA stabilization. Here, we dem- Downloaded from onstrate that the root extract of goldenseal, a BBR-containing regulation of liver LDLR represents a key mechanism by medicinal plant, is highly effective in upregulation of liver which therapeutic agents could intervene in the develop- LDLR expression in HepG2 cells and in reducing plasma ment of coronary heart disease and atherosclerosis. cholesterol and low density lipoprotein cholesterol (LDL-c) Hepatic LDLR expression is predominantly regulated in hyperlipidemic hamsters, with greater activities than the at the transcriptional level through a negative feedback pure compound BBR. By conducting bioassay-driven semi- mechanism by intracellular cholesterol pools. This regu- www.jlr.org purifications, we demonstrate that the higher potency of lation is controlled through specific interactions of the goldenseal is achieved through concerted actions of multi- sterol-regulatory element of the LDLR promoter (5, 6) ple bioactive compounds in addition to BBR.
    [Show full text]
  • Biobiopha Cat 1.Xlsx
    BBP No. Chemical Name CAS No. Structure M. F. M. W. Descr. Type O H H N BBP00001 Gelsemine 509-15-9 C20 H22 N2O2 322.4 Powder Alkaloids N O H N H BBP00002 Koumine 1358-76-5 C20 H22 N2O 306.4 Powder Alkaloids H N O H O BBP00003 Humantenmine 82354-38-9 N C19 H22 N2O3 326.4 Cryst. Alkaloids NO O N N H H H BBP00004 Ajmalicine 483-04-5 C21 H24 N2O3 352.4 Cryst. Alkaloids H O O O O OH N BBP00005 Vasicinolone 84847-50-7 C11 H10 N2O3 218.2 Powder Alkaloids N OH O BBP00011 Humantenine 82375-29-9 N C21 H26 N2O3 354.5 Powder Alkaloids NO O OO OH BBP00012 (Z)-Akuammidine 113973-31-2 N C21 H24 N2O3 352.4 Cryst. Alkaloids N H H H N BBP00018 Vasicine 6159-55-3 N C11 H12 N2O 188.2 Powder Alkaloids OH N BBP00023 Vindoline 2182-14-1 H C25 H32 N2O6 456.5 Oil Alkaloids O N OAc H OH COOMe N N H HH BBP00054 Tetrahydroalstonine 6474-90-4 C21 H24 N2O3 352.4 Solid Alkaloids H O O O O OH BBP00058 1H-Indole-3-carboxylic acid 771-50-6 C9H7NO 2 161.2 Powder Alkaloids N H N Pale yellow BBP00061 Canthin-6-one 479-43-6 N C H N O 220.2 Alkaloids 14 8 2 needles O O N BBP00064 Gelsevirine 38990-03-3 C21 H24 N2O3 352.4 Solid Alkaloids NO O + N N BBP00065 Sempervirine 6882-99-1 C19 H16 N2 272.4 Yellow powder Alkaloids OH N BBP00067 Vasicinol 5081-51-6 N C11 H12 N2O2 204.2 Powder Alkaloids OH O H N H BBP60007 Matrine 519-02-8 C15 H24 N2O 248.4 Powder Alkaloids H H N O H N H BBP60008 Oxymatrine 16837-52-8 C15 H24 N2O2 264.4 Powder Alkaloids H H N O OH + N O BBP60009 Jatrorrhizine 3621-38-3 O C20 H20 NO 4 338.4 Yellow powder Alkaloids O O + N O Yellow powder BBP60010 Palmatine
    [Show full text]